![Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial - The Lancet Oncology Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/73d3fa1f-af78-4bbd-99ed-e59fc5ee48ef/gr1_lrg.jpg)
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial - The Lancet Oncology
![In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity | Drug Metabolism & Disposition In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/44/10/1682/F2.large.jpg)
In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity | Drug Metabolism & Disposition
![Proposed fragmentation patters of abiraterone (A), anastrozole (B),... | Download Scientific Diagram Proposed fragmentation patters of abiraterone (A), anastrozole (B),... | Download Scientific Diagram](https://www.researchgate.net/publication/330109051/figure/fig1/AS:721154675331080@1548948081928/Proposed-fragmentation-patters-of-abiraterone-A-anastrozole-B-bicalutamide-C.png)
Proposed fragmentation patters of abiraterone (A), anastrozole (B),... | Download Scientific Diagram
![Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study - European Urology Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study - European Urology](https://www.europeanurology.com/cms/asset/9f70f2ea-c603-4fb4-9959-ca62b8738b90/gr1.jpg)
Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study - European Urology
![Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517320300533-gr2.jpg)
Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect
![Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design - ScienceDirect Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673622003671-gr2.jpg)
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design - ScienceDirect
![Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517320300533-gr8.jpg)
Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect
![Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 ... Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 ...](https://www.thelancet.com/cms/attachment/982bb021-7afd-47df-92c8-590fea56e3c3/gr1_lrg.gif)
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 ...
![Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517320300533-gr7.jpg)